- Home
- TMO vs SYK Comparison
TMO vs SYK Comparison
Compare TMO & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMO
- SYK
- Stock Information
- Founded
- TMO 1956
- SYK 1941
- Country
- TMO United States
- SYK United States
- Employees
- TMO N/A
- SYK N/A
- Industry
- TMO Industrial Machinery/Components
- SYK Medical/Dental Instruments
- Sector
- TMO Industrials
- SYK Health Care
- Exchange
- TMO Nasdaq
- SYK Nasdaq
- Market Cap
- TMO 159.1B
- SYK 144.9B
- IPO Year
- TMO N/A
- SYK N/A
- Fundamental
- Price
- TMO $487.77
- SYK $387.39
- Analyst Decision
- TMO Buy
- SYK Buy
- Analyst Count
- TMO 17
- SYK 18
- Target Price
- TMO $587.00
- SYK $429.00
- AVG Volume (30 Days)
- TMO 1.6M
- SYK 1.1M
- Earning Date
- TMO 10-22-2025
- SYK 10-28-2025
- Dividend Yield
- TMO 0.35%
- SYK 0.86%
- EPS Growth
- TMO 7.24
- SYK N/A
- EPS
- TMO 17.30
- SYK 7.55
- Revenue
- TMO $43,212,000,000.00
- SYK $23,818,000,000.00
- Revenue This Year
- TMO $3.38
- SYK $11.73
- Revenue Next Year
- TMO $4.62
- SYK $8.51
- P/E Ratio
- TMO $28.41
- SYK $51.49
- Revenue Growth
- TMO 2.04
- SYK 11.36
- 52 Week Low
- TMO $385.46
- SYK $329.16
- 52 Week High
- TMO $623.77
- SYK $406.19
- Technical
- Relative Strength Index (RSI)
- TMO 54.38
- SYK 48.44
- Support Level
- TMO $475.64
- SYK $381.51
- Resistance Level
- TMO $492.00
- SYK $395.90
- Average True Range (ATR)
- TMO 9.67
- SYK 5.88
- MACD
- TMO -2.20
- SYK -0.42
- Stochastic Oscillator
- TMO 53.16
- SYK 38.27
About TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year end-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (54%).
About SYK Stryker Corporation
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.